stars 1 stars 2 stars 3

HemaSense is Improving patient outcomes and reducing costs of percutaneous interventions by providing healthcare professionals the first early alert system for bleeding complications at the access site during post-op recovery. HemaSense is developing an access site monitor which is used during patient recovery to provide early detection and alert of subcutaneous bleeding events. The HemaSense monitor seamlessly integrates with existing patient recovery workflow and enables early, less costly interventions for patients when small amounts of blood are beginning to accumulate outside the femoral vessel.

HemaSense Questions

Nathan Friedman is the CEO of HemaSense.

4 people are employed at HemaSense.

Top HemaSense Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users